Nadolol and Bendroflumethiazide
- Product NDC
- 0115-5322
- 11-digit product format
- 001155322
- Labeler code
- 0115
- Product ID
- 0115-5322_2669933a-33f4-478a-bd9d-9fe48429bcc9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NADOLOL and BENDROFLUMETHIAZIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Impax Generics
- Application
- ANDA077833
- Marketing category
- ANDA
- Marketing start
- 2007-03-30
- Marketing end
- 0000-00-00
- Substance
- NADOLOL; BENDROFLUMETHIAZIDE
- Active strength
- 80 mg/1; mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0115-5322-01 | Nadolol and Bendroflumethiazide | 100 in 1 BOTTLE | TABLET | 100 | | 6 |
| 0115-5322-02 | Nadolol and Bendroflumethiazide | 500 in 1 BOTTLE | TABLET | 500 | | 6 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| BENDROFLUMETHIAZIDE | ACTIVE INGREDIENT | 5Q52X6ICJI | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 4 | |
| NADOLOL | ACTIVE INGREDIENT | FEN504330V | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 4 | |
| BENDROFLUMETHIAZIDE | ACTIVE MOIETY | 5Q52X6ICJI | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 4 | |
| NADOLOL | ACTIVE MOIETY | FEN504330V | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 4 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 4 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 4 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 4 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 4 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 4 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 4 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0115-5322 | NADOLOL AND BENDROFLUMETHIAZIDE TABLET [IMPAX GENERICS] | 6 | Legacy NDC, 2 package rows | 20160416_d2d226ea-1624-47ee-82bf-e9660b75029f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 0115-5322-01 | 00115532201 | 100 in 1 BOTTLE | Historical |
| 0115-5322-02 | 00115532202 | 500 in 1 BOTTLE | Historical |